16
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Variants of the angiogenic factor vascular endothelial cell growth factor

Pages 981-983 | Published online: 25 Feb 2005

Bibliography

  • FERRARA N, DAVIS-SMYTH T: The biology of vascular endothelial, growth factor. Endocrine Rev. (1997) 18:4–25.
  • ••Excellent review about the biology of VEGF-A and relatedproteins.
  • FERRARA N: Role of vascular endothelial growth factor in, the regulation of angiogenesis. Kidney mt. (1999) 56:794–814.
  • KROLL J, WALTENBERGER J: Regulation der Endothel- ftmktion, und der Angiogenese durch den Vaskuldren Endothelialen Wachstumsfaktor-A (VEGF-A). Z Kardiol (2000) 89:206–218.
  • •Review about VEGF-A with special focus on growth factor therapy in cardiovascular diseases.
  • FERRARA N, CARVER-MOORE K, CHEN H et al: Heterozy-gous embryonic lethality induced by targeted inactiva-tion of the VEGF gene. Nature (1996) 380:435–439.
  • CARMELIET P, FERREIRA V, BREIER G et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. (1996) 380:435–439.
  • CARMELIET P, NG Y-S, NUYENS D et al: Impaired myocardial angiogenesis and ischemic cardiomyopa-thy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. (1999) 5:495–502.
  • ••This paper describes the in vivo function of VEGF-Aisoforms 164 and 188, especially in the heart.
  • LEI JX, JIANG AX, PEI DQ: Identification and characteri-zation of a new splicing variant of vascular endothelial growth factor: VEGF183. BBA Gene Struct. Express. (1998) 1443:400–406.
  • LOSORDO DW, VALE PR, SYMES JF et al.: Gene therapyfor myocardial angiogenesis - Initial clinical results with direct myocardial injection of phVEGF(165) as sole therapy for myocardial ischemia. Circulation (1998) 98:2800–2804.
  • ISNER JM, PIECZEK A, SCHAINFELD R et al.: Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb. Lancet (1996) 348:370–374.
  • ROSENGART TK, PATEL SR, LEE LY et al.: Safety of direct myocardial VEGF121 cDNA adenovirus-mediated angiogenesis gene therapy in conjunction with coronary bypass surgery. Circulation (1998) 98:1–321.
  • HENRY TD, ANNEX BH, AZRIN MA et al.: Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis. Circulation (1999) 101:1–476.
  • LAITINEN M, HARTIKAINEN J, HILTUNEN MO et al.: Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum. Gene Ther. (2000) 11:263–270.
  • WALTENBERGER J: Therapeutic angiogenesis in the heart using peptide growth factors: angiogenesis research entering clinical trials. Angiogenesis (1998) 2:115–117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.